Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 1Phase 2
Study Completion Date
2018-12-31
2018-12-31
NCT02642965Uploaded 04-15-2023
Access via NCI by Request
PDS UID: nci-data-516
A Phase 1/2 Study of CPX-351 (NSC# 775341) Alone Followed by Fludarabine, Cytarabine, and G-CSF (FLAG) for Children With Relapsed Acute Myeloid Leukemia (AML)
Files: NCT02642965-D1![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-csv.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
Data DictionaryNCT02642965-D1-Data-Dictionary_2.pdf
![](/projectdatasphere/Images/icons/icon-csv.png)
DATANCT02642965-D1-Dataset_2.csv
![](/projectdatasphere/Images/icons/icon-pdf.png)
OTHERREADME.pdf